These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30193291)

  • 21. Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term Risk.
    An J; Zhang Y; Zhou H; Zhou M; Safford MM; Muntner P; Moran AE; Reynolds K
    J Am Coll Cardiol; 2023 Feb; 81(7):623-632. PubMed ID: 36792277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
    Helgason H; Eiriksdottir T; Ulfarsson MO; Choudhary A; Lund SH; Ivarsdottir EV; Hjorleifsson Eldjarn G; Einarsson G; Ferkingstad E; Moore KHS; Honarpour N; Liu T; Wang H; Hucko T; Sabatine MS; Morrow DA; Giugliano RP; Ostrowski SR; Pedersen OB; Bundgaard H; Erikstrup C; Arnar DO; Thorgeirsson G; Masson G; Magnusson OT; Saemundsdottir J; Gretarsdottir S; Steinthorsdottir V; Thorleifsson G; Helgadottir A; Sulem P; Thorsteinsdottir U; Holm H; Gudbjartsson D; Stefansson K
    JAMA; 2023 Aug; 330(8):725-735. PubMed ID: 37606673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical risk markers and 10-year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification.
    Akintoye E; Briasoulis A; Afonso L
    Am Heart J; 2017 Nov; 193():95-103. PubMed ID: 29129262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Asgari S; Moosaie F; Orangi M; Sarvghadi F; Khalili D; Azizi F
    J Transl Med; 2021 Jan; 19(1):25. PubMed ID: 33407576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study on the prediction model of atherosclerotic cardiovascular disease in the rural Xinjiang population based on survival analysis.
    Qian X; Keerman M; Zhang X; Guo H; He J; Maimaitijiang R; Wang X; Ma J; Li Y; Ma R; Guo S
    BMC Public Health; 2023 Jun; 23(1):1041. PubMed ID: 37264356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment.
    Yeboah J; Young R; McClelland RL; Delaney JC; Polonsky TS; Dawood FZ; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    J Am Coll Cardiol; 2016 Jan; 67(2):139-147. PubMed ID: 26791059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
    Khera A; Budoff MJ; O'Donnell CJ; Ayers CA; Locke J; de Lemos JA; Massaro JM; McClelland RL; Taylor A; Levine BD
    Circulation; 2018 Oct; 138(17):1819-1827. PubMed ID: 30354651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.
    Mora S; Wenger NK; Cook NR; Liu J; Howard BV; Limacher MC; Liu S; Margolis KL; Martin LW; Paynter NP; Ridker PM; Robinson JG; Rossouw JE; Safford MM; Manson JE
    JAMA Intern Med; 2018 Sep; 178(9):1231-1240. PubMed ID: 30039172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels.
    Karmali KN; Ning H; Goff DC; Lloyd-Jones DM
    J Am Heart Assoc; 2015 Sep; 4(9):e002126. PubMed ID: 26391134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification.
    Ghosh AK; Venkatraman S; Nanna MG; Safford MM; Colantonio LD; Brown TM; Pinheiro LC; Peterson ED; Navar AM; Sterling MR; Soroka O; Nahid M; Banerjee S; Goyal P
    JAMA Cardiol; 2024 Jan; 9(1):55-62. PubMed ID: 38055247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
    de La Harpe R; Thorball CW; Redin C; Fournier S; Müller O; Strambo D; Michel P; Vollenweider P; Marques-Vidal P; Fellay J; Vaucher J
    Eur J Prev Cardiol; 2023 May; 30(7):561-571. PubMed ID: 36652418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
    Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Blood Pressure in the Emergency Department: A Risk Factor for Incident Cardiovascular Disease.
    Oras P; Häbel H; Skoglund PH; Svensson P
    Hypertension; 2020 Jan; 75(1):229-236. PubMed ID: 31786971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of Social Disadvantage Score in Cardiovascular Outcomes and Risk Assessment: Findings From the Multi-Ethnic Study of Atherosclerosis.
    Hammoud A; Chen H; Ivanov A; Yeboah J; Nasir K; Cainzos-Achirica M; Bertoni A; Khan SU; Blaha M; Herrington D; Shapiro MD
    Circ Cardiovasc Qual Outcomes; 2023 Jul; 16(7):e009304. PubMed ID: 37403692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using Predicted Atherosclerotic Cardiovascular Disease Risk for Discrimination of Awake or Nocturnal Hypertension.
    Sakhuja S; Booth JN; Anstey DE; Jaeger BC; Lewis CE; Lloyd-Jones DM; Schwartz JE; Shimbo D; Shikany JM; Sims M; Muntner P
    Am J Hypertens; 2020 Nov; 33(11):1011-1020. PubMed ID: 32657334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the performance of three cardiovascular disease risk scores: the Estonian Biobank cohort study.
    Saar A; Läll K; Alver M; Marandi T; Ainla T; Eha J; Metspalu A; Fischer K
    J Epidemiol Community Health; 2019 Mar; 73(3):272-277. PubMed ID: 30635435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Cardiovascular Events by Type I Central Systolic Blood Pressure: A Prospective Study.
    Lamarche F; Agharazii M; Madore F; Goupil R
    Hypertension; 2021 Feb; 77(2):319-327. PubMed ID: 33307853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Blood Pressure Patterns in Young Adulthood With Cardiovascular Disease and Mortality in Middle Age.
    Yano Y; Reis JP; Lewis CE; Sidney S; Pletcher MJ; Bibbins-Domingo K; Navar AM; Peterson ED; Bancks MP; Kanegae H; Gidding SS; Muntner P; Lloyd-Jones DM
    JAMA Cardiol; 2020 Apr; 5(4):382-389. PubMed ID: 31968050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Interplay of the Global Atherosclerotic Cardiovascular Disease Risk Scoring and Cardiorespiratory Fitness for the Prediction of All-Cause Mortality and Myocardial Infarction: The Henry Ford ExercIse Testing Project (The FIT Project).
    Rifai MA; Qureshi WT; Dardari Z; Keteyian SJ; Brawner CA; Ehrman JK; Ahmed A; Sakr S; Virani SS; Blaha MJ; Al-Mallah MH
    Am J Cardiol; 2019 Aug; 124(4):511-517. PubMed ID: 31221461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.